D.E. Shaw & Co
CBAY

D.E. Shaw & Co’s Cymabay Therapeutics CBAY Stock Holding History

D.E. Shaw & Co’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-150,000
Closed -$3.54M – 4859
2023
Q4 		$3.54M Buy
+150,000
New +$2.67M ﹤0.01% 2200

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

D.E. Shaw & Co's CBAY Position: Q1 2024 in Review

D.E. Shaw & Co sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 636,897 shares — an estimated $15M sold.

D.E. Shaw & Co first reported a position in CBAY in Q4 2018 and held it in 21 quarters. The position peaked at $15M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • D.E. Shaw & Co reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 636,897 Cymabay Therapeutics shares in Q1 2024, an estimated $15M.
  • D.E. Shaw & Co first reported a position in Cymabay Therapeutics in Q4 2018 and held it in 21 quarters.
  • D.E. Shaw & Co's Cymabay Therapeutics position peaked at $15M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.